Development of the formulation of “Artproment®” combined gel for application in sports medicine
DOI:
https://doi.org/10.24959/nphj.14.1988Keywords:
traumas of the locomotor system, combined gel, gel technology, sports medicineAbstract
Based on the data of pharmaco-technological and physico-chemical studies conducted the formulation of the gel with the anti-inflammatory and local anesthetic action under the conditional name “Arthroment ®” has been theoretically and experimentally substantiated in the pharmacy and industrial conditions. It is intended for application in a complex treatment of mechanical injuries and post-traumatic inflammations of extremities soft tissues, diseases of the locomotor apparatus (tendons, muscles and joints), musculoskeletal injuries that are characteristic for sports medicine and sports during the rehabilitation period such as bruises, dislocations, sprains, ruptures of ligaments, tendons, etc. The objects of research were model samples of “Artproment®” gel, which includes such active pharmaceutical ingredients (APhI) in its composition as propolis phenolic hydrophobic drug, articaine hydrochloride, menthol (levomenthol) and rosemary oil, as well as the following excipients: a gelation agent (Ultrez-10 NF carbomer), a neutralizer (trometamol), a preservative, nonaqueous solvent (propylene glycol), ethanol and purified water. The results of the experimental research were used when developing the technological process flowchart for preparing “Artproment®” gel in the conditions of pharmacy production and standard operating procedure on the drug studied. Taking into account the physicochemical properties and according to the research results on solubility of APhI in the composition of the drug the technological process flowchart for manufacturing the combined gel industrially and the project of manufacturing instructions have been developed; technological parameters of its manufacturing have been substantiated; the optimal amount of solvents required for performing each technological stage has been calculated taking into account the solubility of the gel components, consequence and phasing of their mixing, temperature and other parameters affecting the quality and stability of the drug; and the formulation of “Artproment®” combined gel has been tested in the pharmacy and industrial conditions.
References
Воловик Н.В., Ляпунов М.О. // Вісник фармації. – 2001. – №3. – С. 51.
Державна фармакопея України / Державне підприємство «Науково-експертний фармакопейний центр». – 1-е вид. – Х.: РІРЕГ, 2001. – Доп. 1, 2004. – С. 395-397.
Кран О.С., Башура О.Г., Баранова І.І. // Вісник фармації. – 2013. – №3 (75). – С. 18-20.
Михайленко В.В., Тихонов О.І., Котенко О.М. // Вісник фармації. – 2011. – №2 (66). – С. 3-6.
Пат. 80917 Україна (UA), МПК (2013.01), А 61 К 9/06 (2006.01), А 61 К 35/00. Гель для місцевого лікування запальних захворювань опорно-рухового апарату на основі продуктів бджільництва / О.С.Шпичак, О.І.Тихонов, І.І.Баранова; заявник і патентовласник О.С.Шпичак. – № u 2013 00514. – Заявл.: 15.01.2013. Опубл.: 10.06.2013. – Бюл. №11. – 4 с.
Пат. на винахід 105437 Україна (UA), МПК A 61 K 9/06 (2006.01), A 61 K 35/64 (2006.01), A 61 K 36/53 (2006.01), A 61P 17/02 (2006.01). Гель для місцевого лікування запальних захворювань опорно-рухового апарату на основі продуктів бджільництва / О.С.Шпичак, О.І.Тихонов, І.І.Баранова; заявник і патентовласник О.С.Шпичак. – № a 2013 00515. – Заявл.: 15.01.2013. Опубл.: 12.05.2014. – Бюл. №9. – 4 с.
Шпичак О.С., Тихонов О.І. // Фармац. журн. – 2014. – №2. – С. 54-63.
Шпичак О.С., Тихонов О.І., Баранова І.І. // Вісник фармації. – 2012. – №4 (72). – С. 7-11.
Шпичак О.С., Яковлєва Л.В., Шаповал О.М. // Укр. біофармац. журн. – 2014. – №1 (30). – С. 33-38.
Botek M., McKune A.J., Krejci J. et al. // Int. J. Sports Med. – 2014. – Vol. 35, №6. – P. 482-488.
Buchheit M., Mendez-Villanueva A., Mayer N. et al. // Int. J. Sports Med. – 2014. – Vol. 35, №6. – P. 494-504.
Carbomers. – European Pharmacopoeia, 2000. – P. 488-489.
Deepa T. Vasudevan, S. Gopalakrishnan, Kavitha R. Dinesh et al. // As. J. Pharm. – 2011. – Vol. 5, №2. – P. 120-124.
Encyclopedia of pharmaceutical technology / Ed. by J.Swarbrick. – 3-rd ed. – NY: Informa Healthcare USA, Inc., 2007. – 4372 p.
Hammond L.E., Lilley J.M., Pope G.D., Ribbans W.J. // Scand. J. Med. Sci. Sports. – 2014. – Vol. 24, №3. – P. 195-200.
Knezevic O.M., Mirkov D.M., Kadija M. et al. // J. of Strength & Conditioning Res. – 2014. – Vol. 28, №6. – P. 1722-1731.
Lauersen J.B., Bertelsen D.M., Andersen L.B. // Br. J. Sports. Med. – 2014. – Vol. 48, №11. – P. 871-877.
Ofner C.M. Gels and jellies / C.M.Ofner, C.M.Klech-Gelotte. Encyclopedia of Pharmaceutical Teсhnology / Ed. by J.Swarbrick, J.C.Boylan. – 2-nd ed. – New York; Basel: Marsel Dekker, 2002. – Vol. 2. – P. 1327-1344.
Downloads
Published
Issue
Section
License
Copyright (c) 2014 National University of Pharmacy
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).